Compound 2466
Identifiers
- Canonical SMILES:
COc1ccc(cc1)S(=O)(=O)Cc1ccc(N([C@@H](C)C(O)=O)S(=O)(=O)c2ccc(OC)cc2)c2ccccc12
- IUPAC name:
(2S)-2-(N-{4-[(4-methoxybenzenesulfonyl)methyl]naphthalen-1-yl}4-methoxybenzenesulfonamido)propanoic acid
- InChi:
InChI=1S/C28H27NO8S2/c1-19(28(30)31)29(39(34,35)24-15-11-22(37-3)12-16-24)27-17-8-20(25-6-4-5-7-26(25)27)18-38(32,33)23-13-9-21(36-2)10-14-23/h4-17,19H,18H2,1-3H3,(H,30,31)/t19-/m0/s1
- InChiKey:
ZGCAXGWKZBFCEZ-IBGZPJMESA-N
External links
![]() 139559930 |
![]() CHEMBL4647946 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Keap1 / Nrf2 | 6.62 | chronic obstructive pulmonary disease , multiple sclerosis , chronic kidney disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 569.12 g/mol | |||
HBA | 9 | |||
HBD | 1 | |||
HBA + HBD | 10 | |||
AlogP | 4.12 | |||
TPSA | 130.11 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acsmedchemlett.9b00631 | 23 | KEAP1 Q9Z2X8 |
NF2L2 Q60795 |
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 6.62 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5591 | N-[(4-methoxyphenyl)sulfonyl]-D-alanine | DB08599 | |
0.5000 | N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE | DB07944 | |
0.4880 | Sivelestat | DB12863 | |
0.4872 | (2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide | DB08609 | |
0.4805 | [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID | DB07986 | |
0.4783 | N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan | DB07233 | |
0.4698 | N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid | DB08105 | |
0.4698 | N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid | DB08106 | |
0.4667 | N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID | DB08107 | |
0.4659 | N,O-Didansyl-L-Tyrosine | DB03157 | |
0.4575 | TO-901317 | DB07080 | |
0.4527 | Tosyl-D-Proline | DB02752 | |
0.4512 | 1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE | DB07273 | |
0.4506 | N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID | DB08108 | |
0.4462 | 3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid | DB02449 |